Assia
Assia Angelova, Sofia BG
Patent application number | Description | Published |
---|---|---|
20110020287 | Parvovirus Cancer Therapy and Combination with Chemotherapy - Described is a pharmaceutical composition containing (a) a parvovirus and (b) a chemotherapeutic agent, preferably as separate entities. The parvovirus might be based on parvovirus H1, LuIII, Mouse minute virus (MMV), Mouse parvovirus (MPV), Rat minute virus (RMV), Rat parvovirus (RPV), Rat virus (RV), vectors based on the foregoing viral species, and/or cells capable of actively producing the foregoing viral species. The pharmaceutical composition is beneficial for the treatment of a tumor. Tumors for which a parvovirus or the adjunction of the invention has particular utility include glioma, medulloblastoma, meningioma and pancreatic cancer. Preferred chemotherapeutic agents are gemcitabine and Temozolodine. | 01-27-2011 |
20140234261 | Parvovirus Cancer Therapy and Combination with Chemotherapy - Described is a pharmaceutical composition containing (a) a parvovirus and (b) a chemotherapeutic agent, preferably as separate entities. The parvovirus might be based on parvovirus H1, LuIII, Mouse minute virus (MMV), Mouse parvovirus (MPV), Rat minute virus (RMV), Rat parvovirus (RPV), Rat virus (RV), vectors based on the foregoing viral species, and/or cells capable of actively producing the foregoing viral species. The pharmaceutical composition is beneficial for the treatment of a tumor. Tumors for which a parvovirus or the adjunction of the invention has particular utility include glioma, medulloblastoma, meningioma and pancreatic cancer. Preferred chemotherapeutic agents are gemcitabine and Temozolodine. | 08-21-2014 |
Assia Barkal, Jeruslaem IL
Patent application number | Description | Published |
---|---|---|
20140205234 | VERTICAL OPTICAL COUPLER FOR PLANAR PHOTONIC CIRCUITS - Described herein are an apparatus, system, and method for providing a vertical optical coupler (VOC) for planar photonics circuits such as photonics circuits fabricated on silicon-on-insulator (SOI) wafers. In one embodiment, the VOC comprises a waveguide made from a material having refractive index in a range of 1.45 to 3.45, the waveguide comprising: a first end configured to reflect light nearly vertical by total internal reflection between the waveguide and another medium, a second end to receive the light for reflection, and a third end to output the reflected light. The VOC couples with a Si waveguide having a first region including: a first end to receive light; and an inverted tapered end in the direction of light propagation to output the received light, wherein the inverted tapered end of the Si waveguide is positioned inside the waveguide. | 07-24-2014 |
Assia Dembri, Paris FR
Patent application number | Description | Published |
---|---|---|
20110207685 | Oral Formulations of Chemotherapeutic Agents - The present invention is directed to new oral formulations of chemotherapeutic agents, their process of preparation as well as their therapeutic uses. More specifically, said invention is related to nanoparticles comprising at least one chemotherapeutic agents as an active ingredient, at least one polymer and at least one cyclic oligosaccharide capable of complexing said camptothecin derivative, said nanoparticles being for therapeutic oral administration. | 08-25-2011 |
Assia El Jaafari, Vourles FR
Patent application number | Description | Published |
---|---|---|
20140308261 | HLA-DR7 HY epitope and method for treating leukaemia - This invention concerns HY epitopic polypeptides specifically presented by the HLA-DR7 molecule, a method for preparing these epitopic polypeptides, isolated T-lymphocytes capable of specifically recognizing an epitope from these polypeptides or from a polypeptide comprising the complete sequence of the protein encoded by the RPS4Y gene and presented by the HLA-DR7 molecule expressed on the surface of antigen-presenting cells, a method for preparing these T-lymphocytes, as well as the use of these epitopic polypeptides and these T-lymphocytes as medicaments, in particular for the treatment of cancers of immune cells. | 10-16-2014 |
Assia Ouchchen, Lokeren BE
Patent application number | Description | Published |
---|---|---|
20110217758 | INCORPORATION OF THERMO-RESISTANT AND/OR PRESSURE-RESISTANT ORGANISMS IN MATERIALS - The present application relates to methods for producing materials having viable micro-organisms incorporated therein. More particularly, the materials are produced under high temperature and/or high pressure conditions, and the microganisms are incorporated in the material before or during these conditions. Also provided are micro-organisms that remain viable under these conditions and have different applications, depending on the nature of the material. | 09-08-2011 |
Assia Petrova Borislavova, Montcada I Reixac ES
Patent application number | Description | Published |
---|---|---|
20140359974 | HINGE DEVICE FOR THE ARTICULATED ATTACHMENT OF A HOOD TO A VEHICLE CHASSIS - The present invention relates to a hinge device for the articulated attachment of a hood to a vehicle chassis, the device comprising a lower bar and an upper bar attached to one another in an articulated manner; a retaining mechanism which, in a retaining position (R), maintains the angle α formed by the lower and upper bars and fastens the assembly formed by said bars to a support body such that the device adopts a compact shape; and an actuator capable of moving the retaining mechanism to a release position (L), disabling the function of the mentioned retaining mechanism, the device being prepared for adopting at least two different collapsed shapes (A and B) without the actuator moving the retaining mechanism to its release position (L) depending on the location of the resultant of a vertical downward force (F) transmitted to the upper bar of the device, caused by hitting a pedestrian, for example. | 12-11-2014 |